TGA update on pain killer cancellation
The Therapeutics Goods Administration (TGA) has issued an update about the regulatory status of dextropoxyphene-containing pain killers following a preliminary decision by the Administrative Appeal Tribunal (AAT).
The TGA, said their position regarding the “poor safety and efficacy profile” of the four pain killers: Capadex, Di-Gesic, Doloxene and Paradex, had not changed as a result of the AAT’s preliminary decision.
In December 2011, the TGA decided to cancel the painkillers from the Australian Register of Therapeutic Goods (ARTG), from 1 March 2012.
The TGA found the safety risks of using painkillers containing dextropoxyphene outweighed the benefits that may be provided by use of these medicines.
On 16 February 2012, the AAT granted a stay on the...
This site is intended for Registered Medical Practitioners.
To make the most of Pharmacy News, you need to be logged in.